Amylyx Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Amylyx Pharmaceuticals, Inc. has filed 414 SEC EDGAR filings since 17 Nov 2015

SEC filing history

Showing 176-200 of 414 matching filings.

Per page
25
Current page
8
4

4

Filing date
07 Jun 2024
Reporting date
06 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 May 2024
Reporting date
15 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41199

144 filing

Filing date
15 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-41199

ARS

Filing date
24 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-41199

DEFA14A

Filing date
24 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41199

DEF 14A

Filing date
24 Apr 2024
Reporting date
06 Jun 2024
Next action
Verify source filing
4

4

Filing date
18 Apr 2024
Reporting date
16 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Apr 2024
Reporting date
16 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Apr 2024
Reporting date
16 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Apr 2024
Reporting date
16 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Apr 2024
Reporting date
16 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Mar 2024
Reporting date
14 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
15 Mar 2024
Reporting date
14 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93265

SC 13G

Filing date
11 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Mar 2024
Reporting date
05 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Mar 2024
Reporting date
05 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Mar 2024
Reporting date
05 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .